References
- Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010;28:1349–55
- Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;33:130–7
- Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99
- Pottecher T, Luton D. Prise en charge multidisciplinaire de la prééclampsie. Issy Les Moulineaux, France: Elsevier Masson SAS; 2009
- Rochat RW, Koonin LM, Atrash HF, et al. Maternal mortality in the United States: report from the Maternal Mortality Collaborative. Obstet Gynecol 1988;72:91–7
- Fisher SJ, McMaster M, Roberts M. The placenta in normal pregnancy and preeclampsia. Chesley’s hypertensive disorders in pregnancy. Amsterdam, the Netherlands: Academic Press, Elsevier; 2009
- Nilsson E, SalonenRos H, Cnattingius S, Lichtenstein P. The importance of genetic and environmental effects for preeclampsia and gestational hypertension: a family study. BJOG 2004;111:200–6
- Prefumo F, Sebire NJ, Thilaganathan B. Decreased endovascular trophoblast invasion in first trimester pregnancies with highresistance uterine artery Doppler indices. Hum Reprod 2004;19:206–9
- Morris RK, Cnossen JS, Langejans M, et al. Serum screening with Down’s syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and metaanalysis. BMC Pregn Childbirth 2008;8:33
- Harrington D, Fayyad A, Thakur V, Aquilina J. The value of uterine artery Doppler in the prediction of uteroplacental complication in multiparous women. Ultrasound Obstet Gynecol 2004;23:50–5
- Gomez O, Martinez JM, Figueras F, et al. Uterine artery Doppler at 11–14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound Obstet Gynecol 2005;26:490–4
- Van-den Elzen HJ, Cohen-Overbeek TE, Grobbee DE, et al. Early uterine artery Doppler velocimetry and the outcome of pregnancy in women aged 35 years and older. Ultrasound Obstet Gynecol 1995;5:328–33
- Pilalis A, Souka AP, Antsaklis P, et al. Screening for preeclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11–14 weeks’ gestation. Ultrasound Obstet Gynecol 2007;29:135–40
- Crovetto F, Fiqueras F, Triunfo S, et al. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters and angiogenic factors. Prenat Diagn 2014 [Epub ahead of print]. doi: 10.1002/pd.4519
- Jonson MR, Riddle AF, Sharma V, et al. The role of trophoblast dysfunction in the etiology of miscarriage. Br J Obstet Gynecol 1993;100:353–9
- Pedersen JF, Sorensen S, Ruge S. Human placental lactogen and pregnancy-associated plasma protein-A in first trimester and subsequent fetal growth. Acta Obstet Gynecol Scand 1995;74:505–8
- Di Lorenzo G, Ceccarello M, Cecotti V, et al. First trimester maternal serum PlGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia. Placenta 2012;33:495–501
- Morssink LP, Kornman LH, Hallahan TW, et al. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 1998;18:147–52
- Spencer K, Yu CK, Cowans NJ, et al. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler. Prenat Diagn 2005;25:949–53
- Kuc S, Wortelboer EJ, van Rijn BB, et al. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 2011;66:225–39